Trial intelligence / Profile preview

TRF-1101 in sickle cell disease

NCT00773890Phase 2Terminated

Sponsor
TRF Pharma
Start
Jul 2008
Primary completion
May 2009
Countries
1
01

Overview

A Phase 2 trial of pentosan polysulfate sodium in sickle cell disease (SCD), sponsored by TRF Pharma. Started Jul 2008; status: terminated.

02

Drugs

pentosan polysulfate sodium
03

Conditions

sickle cell disease (SCD)

Beyond the preview

Go deeper on NCT00773890.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00773890.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call